Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 57 min ago
PreprintAll rights reservedbioRxiv

In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma

  • R. Delara
  • V. Mujumdar
  • Q. Zhang
  • H. Dryden
  • E. Crane
  • J. Brown
  • W. Naumann
  • A. Puechl
  • D. Foureau
  • W. Sha
  • J. LeGrand
  • H.-T. Yang
6 more authors
  • K. Dykema
  • B. Yada
  • C. C. McHale
  • K. Maddeboina
  • D. Pal
  • D. L. Durden1
  1. 1Atrium Health Wake Forest Baptist
Read full textPDFDOICite

Related

  1. Case Report: Primary endometrioid adenocarcinoma of the cervix and secondary cervical involvement by endometrial carcinoma: diagnostic pitfalls and an integrated approach based on two cases
    Lina Geng, Tianci Fan, Guanwen Gao +2
    Frontiers in reproductive healthPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma
    Linger Li, Xin Gao, Siqi Zhang +14
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  3. Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
    Chih-Wen Su, Shao-Jing Wang, Yu-Hsiang Shih +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma
    Alexander K Tsai, Meagan R Rollins, Madeline A Ellefson +17
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full text1 citedOncologyPMC
  5. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    A. Oaknin, T.J. Bosse, C.L. Creutzberg +9
    Annals of OncologyPeer-reviewedCC BY-NC-NDFull text660 citedObstetrics, gynaecology & paediatricsHAL

Cite

BibTeXRIS
BibTeX
@misc{delara2026silico,
  title = {{In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma}},
  author = {R. Delara and V. Mujumdar and Q. Zhang and H. Dryden and E. Crane and J. Brown and W. Naumann and A. Puechl and D. Foureau and W. Sha and J. LeGrand and H.-T. Yang and K. Dykema and B. Yada and C. C. McHale and K. Maddeboina and D. Pal and D. L. Durden},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.28.747865},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.28.747865v1},
}
RIS
TY  - UNPB
TI  - In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma
AU  - R. Delara
AU  - V. Mujumdar
AU  - Q. Zhang
AU  - H. Dryden
AU  - E. Crane
AU  - J. Brown
AU  - W. Naumann
AU  - A. Puechl
AU  - D. Foureau
AU  - W. Sha
AU  - J. LeGrand
AU  - H.-T. Yang
AU  - K. Dykema
AU  - B. Yada
AU  - C. C. McHale
AU  - K. Maddeboina
AU  - D. Pal
AU  - D. L. Durden
PY  - 2026
DA  - 2026/08/28
PB  - bioRxiv
DO  - 10.64898/2026.08.28.747865
UR  - https://www.biorxiv.org/content/10.64898/2026.08.28.747865v1
ER  -